Overview

Comparison of Injections of Botulinum Toxin and Topical Nitroglycerin Ointment for the Treatment of Chronic Anal Fissure

Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
0
Participant gender:
All
Summary
Patients will be randomized to receive treatment with either a total of 20 U of botulinum toxin(diluted in saline to a concentration of 50 U per milliliter.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Pak Emirates Military Hospital
Criteria
Inclusion Criteria:

- Clinical diagnosis: evidence of posterior circumscribed ulcer, with a large sentinel
tag of skin, induration at the edges, and exposure of the horizontal fibers of the
internal anal sphincter

- symptoms (post-defecatory or nocturnal pain, bleeding, or both) lasting for more than
two months.

Exclusion Criteria:

- Patients with acute fissure

- fissure associated with other conditions (i.e., inflammatory bowel diseases, HIV
infection, hemorrhoids, fistula in ano, anal abscesses, or anal or perianal cancer)

- those who had undergone previous surgical procedures in the anal canal.

- known hypersensitivity to component of the formulations of type A BTX

- pregnant or breast-feeding women 6-refusal of consent